State Street’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,027
| Closed | -$257K | – | 4302 |
|
|
2025
Q1 | $257K | Sell |
28,027
-3
| -0% | -$19 | ﹤0.01% | 3766 |
|
|
2024
Q4 | $187K | Buy |
28,030
+5,276
| +23% | +$46.4K | ﹤0.01% | 3869 |
|
|
2024
Q3 | $229K | Buy |
22,754
+2,834
| +14% | +$41.3K | ﹤0.01% | 3793 |
|
|
2024
Q2 | $311K | Sell |
19,920
-70,942
| -78% | -$1.19M | ﹤0.01% | 3685 |
|
|
2024
Q1 | $1.99M | Buy |
90,862
+4,501
| +5% | +$99.9K | ﹤0.01% | 3281 |
|
|
2023
Q4 | $1.67M | Sell |
86,361
-1,513
| -2% | -$27.6K | ﹤0.01% | 3363 |
|
|
2023
Q3 | $1.62M | Buy |
87,874
+5,826
| +7% | +$105K | ﹤0.01% | 3409 |
|
|
2023
Q2 | $1.51M | Buy |
82,048
+68,238
| +494% | +$1.61M | ﹤0.01% | 3496 |
|
|
2023
Q1 | $400K | Hold |
13,810
| – | – | ﹤0.01% | 3819 |
|
|
2022
Q4 | $383K | Sell |
13,810
-87
| -0.6% | -$3.3K | ﹤0.01% | 3860 |
|
|
2022
Q3 | $763K | Buy |
13,897
+100
| +0.7% | +$5.49K | ﹤0.01% | 3654 |
|
|
2022
Q2 | $757K | Buy |
13,797
+2,027
| +17% | +$74.6K | ﹤0.01% | 3691 |
|
|
2022
Q1 | $436K | Buy |
11,770
+5,504
| +88% | +$197K | ﹤0.01% | 4111 |
|
|
2021
Q4 | $152K | Hold |
6,266
| – | – | ﹤0.01% | 4455 |
|
|
2021
Q3 | $282K | Hold |
6,266
| – | – | ﹤0.01% | 4225 |
|
|
2021
Q2 | $292K | Sell |
6,266
-32,255
| -84% | -$1.65M | ﹤0.01% | 4063 |
|
|
2021
Q1 | $2.13M | Buy |
38,521
+223
| +0.6% | +$13.6K | ﹤0.01% | 3416 |
|
|
2020
Q4 | $2.38M | Buy |
38,298
+748
| +2% | +$45.8K | ﹤0.01% | 3294 |
|
|
2020
Q3 | $2.2M | Buy |
37,550
+1,825
| +5% | +$135K | ﹤0.01% | 3163 |
|
|
2020
Q2 | $3.99M | Buy |
35,725
+1,397
| +4% | +$99.4K | ﹤0.01% | 2871 |
|
|
2020
Q1 | $2.31M | Buy |
34,328
+2,756
| +9% | +$278K | ﹤0.01% | 2998 |
|
|
2019
Q4 | $4.37M | Buy |
31,572
+2,437
| +8% | +$316K | ﹤0.01% | 2904 |
|
|
2019
Q3 | $3.06M | Buy |
29,135
+2,041
| +8% | +$204K | ﹤0.01% | 3050 |
|
|
2019
Q2 | $2.88M | Buy |
27,094
+5,951
| +28% | +$784K | ﹤0.01% | 3087 |
|
|
2019
Q1 | $3.27M | Buy |
21,143
+531
| +3% | +$61.6K | ﹤0.01% | 2950 |
|
|
2018
Q4 | $1.92M | Buy |
20,612
+1,530
| +8% | +$218K | ﹤0.01% | 3136 |
|
|
2018
Q3 | $3.56M | Buy |
19,082
+3,625
| +23% | +$1.03M | ﹤0.01% | 3025 |
|
|
2018
Q2 | $6.49M | Buy |
15,457
+12,401
| +406% | +$4.18M | ﹤0.01% | 2736 |
|
|
2018
Q1 | $917K | Buy |
3,056
+1,400
| +85% | +$388K | ﹤0.01% | 3351 |
|
|
2017
Q4 | $469K | Buy |
+1,656
| New | +$466K | ﹤0.01% | 3460 |
|
State Street's OPTN Position: Q2 2025 in Review
State Street sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 28,027 shares — an estimated $257K sold.
State Street first reported a position in OPTN in Q4 2017 and held it in 30 quarters. The position peaked at $6.49M in Q2 2018. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- State Street reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- State Street sold 28,027 OptiNose shares in Q2 2025, an estimated $257K.
- State Street first reported a position in OptiNose in Q4 2017 and held it in 30 quarters.
- State Street's OptiNose position peaked at $6.49M in Q2 2018.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.